Hemorrhage and the use of blood products after adult cardiac operations: myths and realities.

[1]  S. Bélisle,et al.  Reduction in requirements for allogeneic blood products: nonpharmacologic methods. , 1996, The Annals of thoracic surgery.

[2]  M. Janssens,et al.  Treatment of excessive mediastinal bleeding after cardiopulmonary bypass. , 1996, The Annals of thoracic surgery.

[3]  S. Kleinman,et al.  The Risk of Transfusion-Transmitted Viral Infections , 1996 .

[4]  T. Ivert,et al.  Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  E. Spitznagel,et al.  The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. , 1995, The Journal of thoracic and cardiovascular surgery.

[6]  D. Jobes,et al.  Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. , 1995, The Journal of thoracic and cardiovascular surgery.

[7]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[8]  S. Body,et al.  ICU ENTRY HEMATOCRIT DOES INFLUENCE THE RISK FOR PERIOPERATIVE MYOCARDIAL INFARCTION (MI) IN CORONARY ARTERY BYPASS GRAFT SURGERY , 1995 .

[9]  U. Schött,et al.  Perioperative autotransfusion and functional coagulation analysis in total hip replacement , 1995, Acta anaesthesiologica Scandinavica.

[10]  W. van Oeveren,et al.  Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. , 1995, The Annals of thoracic surgery.

[11]  B. Spiess,et al.  Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. , 1995, Journal of cardiothoracic and vascular anesthesia.

[12]  S. Ferraris,et al.  1988: Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Updated in 1995. , 1995, The Annals of thoracic surgery.

[13]  S. Brister,et al.  Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. , 1995, The Canadian journal of cardiology.

[14]  M. Blajchman,et al.  Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. , 1995, Hematology/oncology clinics of North America.

[15]  P D Mintz,et al.  Quality assessment and improvement of transfusion practices. , 1995, Hematology/oncology clinics of North America.

[16]  A. Sturk,et al.  Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[17]  G. Paone,et al.  Blood conservation in coronary artery surgery. , 1994, Surgery.

[18]  D. Reich,et al.  Aspirin Does Not Increase Homologous Blood Requirements in Elective Coronary Bypass Surgery , 1994 .

[19]  L. Goodnough,et al.  The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery , 1994, Transfusion.

[20]  G. Guiraudon,et al.  Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. , 1994, The Journal of thoracic and cardiovascular surgery.

[21]  F. Schildberg,et al.  Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery , 1993, The Lancet.

[22]  D. Loisance,et al.  [Aprotinin in cardiac surgery in patients with platelet anti-aggregant treatment]. , 1993, Archives des maladies du coeur et des vaisseaux.

[23]  J. Linden,et al.  Blood donor‐, apheresis‐, and transfusion‐related activities: results of the 1991 American Association of Blood Banks Institutional Membership Questionnaire , 1993, Transfusion.

[24]  J. Essell,et al.  Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass. , 1993, Journal of cardiothoracic and vascular anesthesia.

[25]  G. Hicks,et al.  Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[26]  W. Dietrich,et al.  High-dose aprotinin in cardiac surgery: three years' experience in 1,784 patients. , 1992, Journal of cardiothoracic and vascular anesthesia.

[27]  J. Desroches,et al.  Natural and synthetic antifibrinolytics in cardiac surgery , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[28]  R. Panush,et al.  Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? , 1991, Archives of internal medicine.

[29]  M. Carrier,et al.  The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[30]  C. Madden.  Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease: The RISC Group Lancet 336: 827–830 Oct 1990 , 1991 .

[31]  L. Goodnough,et al.  The Variability of Transfusion Practice in Coronary Artery Bypass Surgery , 1991 .

[32]  F. Grover,et al.  Identification of patients at greatest risk for developing major complications at cardiac surgery. , 1990, Circulation.

[33]  W. Scott,et al.  Blood conservation in cardiac surgery. , 1990, The Annals of thoracic surgery.

[34]  D. Wheatley,et al.  Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. , 1990, The Annals of thoracic surgery.

[35]  J. Avorn,et al.  Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. Implications for practice change strategies. , 1990, JAMA.

[36]  L. Czer.  Mediastinal bleeding after cardiac surgery: etiologies, diagnostic considerations, and blood conservation methods. , 1989, Journal of cardiothoracic anesthesia.

[37]  A. Whittemore.  Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study: Steven Goldman MD, Jack Copeland, MD, Thomas Moritz, MS, et al. Circulation 1988;77:1324-32 , 1989 .

[38]  V Gildengorin,et al.  Predictors of excessive blood use after coronary artery bypass grafting. A multivariate analysis. , 1989, The Journal of thoracic and cardiovascular surgery.

[39]  H. Adams,et al.  A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. , 1989, The New England journal of medicine.

[40]  T. Juji,et al.  Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan. , 1989, The New England journal of medicine.

[41]  N. Nussinovitch,et al.  The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. , 1989, The New England journal of medicine.

[42]  T. Ferguson,et al.  Blood conservation in cardiac surgery. Preliminary results with an institutional commitment. , 1989, Annals of surgery.

[43]  J. Scott,et al.  The importance of cytomegalovirus in heart-lung transplant recipients. , 1989, Chest.

[44]  Thomas E. Moritz,et al.  Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. , 1988, Circulation.

[45]  V. Fuster,et al.  Usefulness of aspirin for coronary artery disease. , 1988, The American journal of cardiology.

[46]  F. Orzan,et al.  Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. , 1987, The Annals of thoracic surgery.

[47]  N. Ellison,et al.  A Survey of Transfusion Practices among Anesthesiologists , 1987, Vox sanguinis.

[48]  M. Talamonti,et al.  Early reexploration for excessive postoperative bleeding lowers wound complication rates in open heart surgery. , 1987, The American surgeon.

[49]  T. Juji,et al.  POST-TRANSFUSION GRAFT-VERSUS-HOST DISEASE AFTER OPEN HEART SURGERY , 1986, The Lancet.

[50]  W. Klepetko,et al.  Risk factors for severe bacterial infections after valve replacement and aortocoronary bypass operations: analysis of 246 cases by logistic regression. , 1985, The Annals of thoracic surgery.

[51]  T. Merigan,et al.  Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy. , 1983, The Journal of infectious diseases.

[52]  P. Clifford,et al.  Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. , 1982, The New England journal of medicine.

[53]  V. Fuster,et al.  A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. , 1982, The New England journal of medicine.

[54]  E. Michelson,et al.  Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass graft surgery. , 1978, The Journal of thoracic and cardiovascular surgery.

[55]  E. Michelson,et al.  Aspirin- and coumadin-related bleeding after coronary- artery bypass graft surgery. , 1978, Annals of internal medicine.

[56]  E. Salzman,et al.  Intermediate syndrome of platelet dysfunction. , 1978, Blood.

[57]  R. Newcombe,et al.  MATERNAL DEATHS , 1975, The Lancet.

[58]  J. Magovern,et al.  A model for predicting transfusion after coronary artery bypass grafting. , 1996, The Annals of thoracic surgery.

[59]  P. Biglioli,et al.  The effect of "high dose" aprotinin and other factors on bleeding and revisions for bleeding in adult coronary and valve operations: an analysis of 2190 patients during a five-year period (1987-1991). , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[60]  R. Bowden.  Transfusion-transmitted cytomegalovirus infection. , 1995, Immunological investigations.

[61]  G. Tangen,et al.  Consistent non-pharmacologic blood conservation in primary and reoperative coronary artery bypass grafting. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[62]  G. Bashein,et al.  Preoperative aspirin therapy and reoperation for bleeding after coronary artery bypass surgery. , 1991, Archives of internal medicine.

[63]  J. Jones,et al.  A prospective study of aspirin's effect on red blood cell loss in cardiac surgery. , 1991, The Journal of cardiovascular surgery.

[64]  Thomas E. Moritz,et al.  Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. , 1990, Journal of the American College of Cardiology.

[65]  S. Ferraris,et al.  Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. , 1988, The Annals of thoracic surgery.